XML 61 R44.htm IDEA: XBRL DOCUMENT v3.24.1.u1
SHARE-BASED COMPENSATION (Tables)
12 Months Ended
Dec. 31, 2023
Summary of the share options activities

A summary of the share options activities under the Amended 2016 Plan and the 2018 Plan for the year ended December 31, 2023 was presented below:

     

    

Weighted

    

Weighted

    

average

remaining

Aggregate

Number of

 exercise

contractual

intrinsic 

    

shares

    

price

    

years

    

value

US$

US$

Outstanding at January 1, 2023

4,414,608

2.11

Exercised

(464,300)

0.20

Forfeited/Expired

(7,250)

0.20

Outstanding at December 31, 2023

3,943,058

2.34

4.56

1,190,466

Exercisable as of December 31, 2023

3,943,058

2.34

4.56

1,190,466

Summary of the restricted share units activities

A summary of the restricted share units activities for the year ended December 31, 2023 was presented below:

    

    

Weighted

average grant

Number of

date fair

shares

value

US$

Unvested as of January 1, 2023

 

3,890,658

4.59

Granted

 

232,000

2.31

Vested

(1,507,862)

4.44

Forfeited

(611,722)

4.30

Unvested as of December 31, 2023

 

2,003,074

4.53

Schedule of share-based compensation expenses recognized

Total share-based compensation expenses recognized for the years ended December 31, 2021, 2022 and 2023 were allocated to the following expense items:

 

For the Year Ended

December 31,

 

2021

    

2022

    

2023

    

RMB

    

RMB

    

RMB

Cost of revenues

 

846,833

1,224,796

1,237,902

Selling and marketing expenses

 

13,292,632

15,433,684

9,991,688

Research and development expenses

 

17,062,024

22,361,742

21,653,946

General and administrative expenses

 

16,016,667

19,198,964

14,775,768

Total share-based compensation expense

 

47,218,156

58,219,186

47,659,304

Share options  
Schedule of share-based compensation expenses recognized

Compensation expenses recognized for share options for the years ended December 31, 2021, 2022 and 2023 were allocated to the following expense items:

 

For the Year Ended

 

December 31, 

    

2021

    

2022

    

2023

    

RMB

RMB

 

RMB

Cost of revenues

 

8,318

Selling and marketing expenses

 

2,235,102

1,936,414

905,764

Research and development expenses

 

4,018,126

3,862,189

2,191,242

General and administrative expenses

 

6,649,255

5,008,382

3,047,542

Total share options compensation expenses

 

12,910,801

10,806,985

6,144,548

No share options had been granted for the years ended December 31, 2021, 2022 and 2023. The total intrinsic value of share options exercised for the years ended December 31, 2021, 2022 and 2023, were RMB77,271,754, RMB3,708,615 and RMB4,799,425, respectively. The total fair value of shares vested for the years ended December 31, 2021, 2022 and 2023 were RMB15,732,201, RMB10,976,490 and RMB11,027,023, respectively.

Unvested restricted share units  
Schedule of share-based compensation expenses recognized

Compensation expenses recognized for restricted share units for the years ended December 31, 2021, 2022 and 2023 were allocated to the following expense items:

For the Year Ended

December 31, 

    

2021

    

2022

    

2023

 

RMB

RMB

RMB

Cost of revenues

 

838,515

1,224,796

1,237,902

Selling and marketing expenses

 

11,057,530

13,497,270

9,085,924

Research and development expenses

 

13,043,898

18,499,553

19,462,704

General and administrative expenses

 

9,367,412

14,190,582

11,728,226

Total restricted share units compensation expenses

 

34,307,355

47,412,201

41,514,756